Close Menu

This story has been updated to include a statement from Bio-Rad Laboratories.

NEW YORK – The US International Trade Commission on Wednesday issued a final determination that 10x Genomics' older GEM microfluidic chips infringed patents held by Bio-Rad Laboratories. ITC also affirmed that 10x's Next GEM product line did not infringe those patents. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

New analyses indicate the P.1 variant found in Brazil may be able to infect people who have already had COVID-19, the New York Times reports.

According to CNBC, Novavax's CEO says its vaccine could be authorized in the US as early as May.

The US National Institutes of Health has a new initiative to address structural racism in biomedical research.

In PNAS this week: GWAS of TLV-1-associated myelopathy/tropical spastic paraparesis, analysis of twins with hypertrophic cardiomyopathy, and more.